308 related articles for article (PubMed ID: 24347127)
41. Serial scanning with technetium pyrophosphate (
Castaño A; DeLuca A; Weinberg R; Pozniakoff T; Blaner WS; Pirmohamed A; Bettencourt B; Gollob J; Karsten V; Vest JA; Chiuzan C; Maurer MS; Bokhari S
J Nucl Cardiol; 2016 Dec; 23(6):1355-1363. PubMed ID: 26453570
[TBL] [Abstract][Full Text] [Related]
42.
Kollikowski AM; Kahles F; Kintsler S; Hamada S; Reith S; Knüchel R; Röcken C; Mottaghy FM; Marx N; Burgmaier M
Intractable Rare Dis Res; 2017 Nov; 6(4):291-294. PubMed ID: 29259858
[TBL] [Abstract][Full Text] [Related]
43. Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis.
Fine NM; Davis MK; Anderson K; Delgado DH; Giraldeau G; Kitchlu A; Massie R; Narayan J; Swiggum E; Venner CP; Ducharme A; Galant NJ; Hahn C; Howlett JG; Mielniczuk L; Parent MC; Reece D; Royal V; Toma M; Virani SA; Zieroth S
Can J Cardiol; 2020 Mar; 36(3):322-334. PubMed ID: 32145862
[TBL] [Abstract][Full Text] [Related]
44. The role of echocardiography and 99mTc-HDP scintigraphy in non-invasive diagnosis of cardiac amyloidosis: A case series and literature review.
Costache II; Buburuz AM; Crisu D; Statescu AM; Ungureanu C; Aursulesei V
Medicine (Baltimore); 2019 Sep; 98(38):e17256. PubMed ID: 31567998
[TBL] [Abstract][Full Text] [Related]
45. The utility of positron emission tomography in cardiac amyloidosis.
Saeed S; Saad JM; Ahmed AI; Han Y; Al-Mallah MH
Heart Fail Rev; 2022 Sep; 27(5):1531-1541. PubMed ID: 34743267
[TBL] [Abstract][Full Text] [Related]
46. The use of PYP scan for evaluation of ATTR cardiac amyloidosis at a tertiary medical centre.
Dower J; Dima D; Lalla M; Patel AR; Comenzo RL; Varga C
Br J Cardiol; 2022; 29(2):19. PubMed ID: 36212788
[TBL] [Abstract][Full Text] [Related]
47. 2021 Advocacy Statements for the Role of
Huang YH; Lin YH; Yen RF; Hou CJ; Wang SY; Tsai SC; Ho KC; Lin MH; Tsao CH; Chang CY; Huang JL; Cheng MF; Wu YW
Acta Cardiol Sin; 2021 May; 37(3):221-231. PubMed ID: 33976505
[TBL] [Abstract][Full Text] [Related]
48. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
Rubin J; Maurer MS
Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
[TBL] [Abstract][Full Text] [Related]
49. Positron emission tomography (PET) utilizing Pittsburgh compound B (PIB) for detection of amyloid heart deposits in hereditary transthyretin amyloidosis (ATTR).
Pilebro B; Arvidsson S; Lindqvist P; Sundström T; Westermark P; Antoni G; Suhr O; Sörensen J
J Nucl Cardiol; 2018 Feb; 25(1):240-248. PubMed ID: 27645889
[TBL] [Abstract][Full Text] [Related]
50. [Bone seeking tracers' scintigraphy for the diagnosis of transthyretin cardiac amyloidosis].
Daquarti GJ; Meretta A; Corneli M; Costabel JP; Diez M; Masoli OH
Medicina (B Aires); 2018; 78(6):395-398. PubMed ID: 30504105
[TBL] [Abstract][Full Text] [Related]
51. Nuclear imaging in cardiac amyloidosis.
Glaudemans AW; Slart RH; Zeebregts CJ; Veltman NC; Tio RA; Hazenberg BP; Dierckx RA
Eur J Nucl Med Mol Imaging; 2009 Apr; 36(4):702-14. PubMed ID: 19156411
[TBL] [Abstract][Full Text] [Related]
52. Nuclear Imaging for the Diagnosis of Cardiac Amyloidosis in 2021.
Li W; Uppal D; Wang YC; Xu X; Kokkinidis DG; Travin MI; Tauras JM
Diagnostics (Basel); 2021 May; 11(6):. PubMed ID: 34070853
[TBL] [Abstract][Full Text] [Related]
53. A case of cardiac amyloidosis incidentally detected by bone scintigraphy.
Tanaka H; Hosono M; Kanagaki M; Shimizu M; Matsubara N; Kawabata K; Miyamoto T; Itoi K
Asia Ocean J Nucl Med Biol; 2021; 9(1):71-75. PubMed ID: 33392354
[TBL] [Abstract][Full Text] [Related]
54. Transthyretin cardiac amyloidosis.
Porcari A; Fontana M; Gillmore JD
Cardiovasc Res; 2023 Feb; 118(18):3517-3535. PubMed ID: 35929637
[TBL] [Abstract][Full Text] [Related]
55. Identification and typing of cardiac amyloidosis by noninvasive imaging: Two cases for two patterns.
Nappi C; Zampella E; Volpe F; De Risi M; Piscopo L; Ponsiglione A; Imbriaco M; Acampa W; Petretta M; Cuocolo A
J Nucl Cardiol; 2020 Jun; 27(3):915-920. PubMed ID: 31845305
[TBL] [Abstract][Full Text] [Related]
56. Recent Advances in Cardiovascular Imaging Relevant to the Management of Patients with Suspected Cardiac Amyloidosis.
White JA; Fine NM
Curr Cardiol Rep; 2016 Aug; 18(8):77. PubMed ID: 27319007
[TBL] [Abstract][Full Text] [Related]
57. Imaging in systemic amyloidosis.
Sachchithanantham S; Wechalekar AD
Br Med Bull; 2013; 107():41-56. PubMed ID: 23896486
[TBL] [Abstract][Full Text] [Related]
58. Current state of cardiac amyloidosis.
Sharma N; Howlett J
Curr Opin Cardiol; 2013 Mar; 28(2):242-8. PubMed ID: 23324855
[TBL] [Abstract][Full Text] [Related]
59. State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis.
Singh V; Falk R; Di Carli MF; Kijewski M; Rapezzi C; Dorbala S
J Nucl Cardiol; 2019 Feb; 26(1):158-173. PubMed ID: 30569412
[TBL] [Abstract][Full Text] [Related]
60. Targeted Nuclear Imaging Probes for Cardiac Amyloidosis.
Bravo PE; Dorbala S
Curr Cardiol Rep; 2017 Jul; 19(7):59. PubMed ID: 28508350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
